SCHEMBL17377396

SCHEMBL17377396

NC(=NO)c1ccc(-c2nnc(-c3ccc(Cl)cc3)o2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
KDM4E B2RXH2 5/20 0.53
HSD17B10 Q99714 4/20 0.53
TP53 P04637 3/20 0.53
TSHR P16473 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NOTUM Q6P988 1/20 0.53
MAOB P27338 2/20 0.50
MAOA P21397 1/20 0.50
ALDH1A1 P00352 3/20 0.47
NFKB1 P19838 1/20 0.47
CASP3 P42574 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
HPGD P15428 2/20 0.46
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17377394 1.00 NPC1 (0.53) NPC1RAB9AKDM4EHSD17B10TP53
SCHEMBL19077678 0.87 NPC1 (0.53) NPC1RAB9AKDM4EHSD17B10TP53
SCHEMBL17377352 0.85 GSK3B (0.63) NPC1RAB9AKDM4ETP53SMN1; SMN2
SCHEMBL17377350 0.85 GSK3B (0.63) NPC1RAB9AKDM4ETP53SMN1; SMN2
SCHEMBL102713 0.80 RAB9A (0.53) NPC1RAB9AKDM4ESMN1; SMN2CASP3
SCHEMBL2706678 0.80 RAB9A (0.53) NPC1RAB9AKDM4ESMN1; SMN2CASP3
SCHEMBL102712 0.80 RAB9A (0.53) NPC1RAB9AKDM4ESMN1; SMN2CASP3
SCHEMBL19075483 0.80 LMNA (0.60) NPC1RAB9AKDM4EHSD17B10TP53
Hydrochloric Acid SCHEMBL17377395 0.79 LMNA (0.63) NPC1RAB9AKDM4EHSD17B10TP53
SCHEMBL21887193 0.78 NPC1 (0.79) NPC1RAB9AKDM4EHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828351-B2 Enzyme interacting agents MONASH UNIVERSITY (AU) 2017-11-28 US disclosed
US-20170190698-A1 ENZYME INTERACTING AGENTS CENTRAL ADELAIDE LOCAL HEALTH NETWORK INCORPORATED (AU) 2017-07-06 US disclosed
EP-3160949-A1 ENZYME INTERACTING AGENTS Monash University (AU) 2017-05-03 EP disclosed
WO-2015196258-A1 ENZYME INTERACTING AGENTS MONASH UNIVERSITY (AU) 2015-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190698-A1 ENZYME INTERACTING AGENTS SMPD1, SMPD2, ASAH1 NPC1 672/4885RAB9A 3204/4885KDM4E 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.